stockhead5d
Dr Boreham’s Crucible: It’s no pain, no gain for this MVP, but can it finally become the GOAT?
No company wants sub-optimal returns on their product – and pain-management house Medical Developments International is no ...
heraldsun.com.au5d
Dr Boreham’s Crucible: It’s no pain, no gain for this MVP, but can it finally become the GOAT?
Colloquially known as the ‘green whistle’, Penthrox’s methoxyflurane is administered to grimacing injured sportspeople as they limp from the field. Of course, jacking up prices is ...
BMJ5d
Non-interventional study evaluating exposure to inhaled, low-dose methoxyflurane experienced by hospital emergency department personnel in France
Objectives Low-dose methoxyflurane is a non-opioid, inhaled analgesic administered via the Penthrox inhaler and was recently licensed in Europe for emergency relief of moderate-to-severe ...
marketindex5d
Medical Developments International Ltd (MVP)
Data supplied by Morningstar and accurate on Sep 11, 2023. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...